If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:105889-45-0
Source:Korea
Qualifications:-/-/-/-/-
Name | Cefcapene pivoxil |
---|---|
Chinese name | 头孢卡品酯 |
Cas Number | 105889-45-0 |
Source | Korea |
Qualifications | -/-/-/-/- |
Cefcapene Pivoxil Hydrochloride is a cephalosporin broad-spectrum antibiotic. It was first developed by Shionoyoshi Pharmaceutical Co., Ltd., and was first marketed in Japan in 1997. It is the fourth-generation oral cephalosporin antibiotic. Cefcapene Pivoxil hydrochloride inhibits the cross-linking of the mucopeptide chain to destroy the cell wall of the bacteria, produces a bactericidal effect, and can bind to the penicillin binding proteins (PBPs) on the cell membrane of bacteria and other pathogens to change the morphology of the bacteria and eventually kill it . Cefcapene Pivoxil against Ceftoren, Cefotiam, Cefditoren, Cefditoren, Cefditoren Strong; it is more active against Proteus, Haemophilus influenzae, Morganella morganella, and Neisseria gonorrhoeae, with a broad antibacterial spectrum, strong antibacterial activity, wide indications, and resistance to resistance specialty. In 2017, global sales of cephalosporins were 11.86 billion U.S. dollars, 12.94 billion U.S. dollars in 2018, and more than 13.5 billion U.S. dollars in 2019. At present, cephalosporin products in the antibiotic market in China account for approximately 40%-45% of the market.
Hot Tags: cefcapene pivoxil api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Cinacalcet Hydrochloride API, Perindopril Tert butylamine Salt API, Active Pharmaceutical Ingredient, Paliperidone API, Lercanidipine Hydrochloride API, Clofarabine API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China